Virtual Counseling for Tobacco Addiction
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently using medication to help quit smoking.
What data supports the effectiveness of the treatment C-Raven for tobacco addiction?
Research shows that virtual interventions, like avatar-led programs, can be effective for smoking cessation. For example, a study found that young adults found an avatar-led digital program grounded in Acceptance and Commitment Therapy (ACT) to be satisfactory and motivating, suggesting that similar virtual treatments could help people quit smoking.12345
Is virtual counseling for tobacco addiction safe for humans?
How is the C-Raven treatment for tobacco addiction different from other treatments?
C-Raven is unique because it uses an avatar (a digital character) to deliver a computerized intervention for quitting smoking, which is different from traditional methods like phone or video counseling. This approach offers a novel, interactive experience that may engage users in a new way compared to standard treatments.29101112
What is the purpose of this trial?
In low-income housing units in Baltimore, the investigators propose to conduct a pilot two-arm hybrid type 1 effectiveness-implementation RCT comparing a) an avatar-delivered computerized intervention (CI) for tobacco cessation augmented with CHW support and navigation to lung cancer screening to b) a waitlist control.With a sample of participants from public housing units (N=30), the investigators will collect data on feasibility of recruitment, intervention engagement and completion, and short-term smoking cessation outcomes. Individuals will be assessed at baseline, 1 month, 3 months, and 6 months. At the 3-month time point, the investigators will conduct interviews with a subset of pilot participants to collect qualitative data on intervention acceptability.
Research Team
Alejandra Ellison-Barnes, MD
Principal Investigator
Johns Hopkins School of Medicine
Eligibility Criteria
This trial is for individuals living in low-income housing units in Baltimore who are struggling with tobacco addiction or use disorder. Participants should be interested in quitting smoking and willing to engage with a virtual cessation program and potentially receive lung cancer screening.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial evaluation including demographics, clinical history, and tobacco use history
Treatment
Participants receive a virtual counselor intervention for smoking cessation and nicotine replacement therapies
Follow-up
Participants are monitored for smoking cessation outcomes and intervention acceptability
Treatment Details
Interventions
- C-Raven
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Walgreens
Collaborator
Maryland Cigarette Restitution Fund
Collaborator
Walgreens
Industry Sponsor